FOX BIZ NEWS: Up 246%: Is This Small-Cap Biotech Stock Still a Buy?

Up 246%: Is This Small-Cap Biotech Stock Still a Buy?



Affimed struck a game-changing deal with Roche yesterday, causing its shares to sky-rocket.